Human Vaccines Market Trend, Share, Growth, Size and Forecast 2032

Human Vaccines Market

Human Vaccines Market Analysis By Product Type (Influenza, Pneumococcal, HPV, Hepatitis, Rotavirus, Meningococcal, Mumps, Measles, Typhoid, and Others), By Vaccine Type (Attenuated, Recombinant, Conjugate, Combination, Inactivated, and Others), By Age Group (Adolescent, Pediatrics, Geriatrics, and Adult), By Distribution Channel (Drugstores, Hospital, Pharmacies, and Others), and By Region: Global Industry Perspective, Comprehensive Analysis, and Forecast 20242032

Category: Healthcare Report Format : PDF Pages: 207 Report Code: ZMR-2806 Published Date: Jun-2024 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 43.51 Billion USD 61.93 Billion 4.0% 2023

 

Human Vaccines Market: Industry Prospective

The global Human Vaccines market size accrued earnings worth approximately USD 43.51 Billion in 2023 and is predicted to gain revenue of about USD 61.93 Billion by 2032, is set to record a CAGR of nearly 4.0% over the period from 2024 to 2032.

Human Vaccines Market SizeRequest Free Sample

The demand for Human Vaccines Market is increasing significantly due to high prevalence of infectious diseases in majorly developing and least developed countries, and increased spending by government agencies on healthcare. Furthermore, advancements in research and development has led to the growth of personalized medicine which will further boost the demand for human vaccines worldwide.

Global Human Vaccines Market: Overview

Vaccination is always been promoted as a very important public health intercession across the world for decades. According to the (WHO) World Health Organization, vaccination has decreased the worldwide burden of contagious disease/syndrome to a great extent. An exceptionally low risk of severe and deadly side effects related to vaccines and increasing understanding related to vaccination by different government and non-profit associations are the most important factors fuelling the global human vaccines market.

Global Human Vaccines Market: Growth Factors

The global human vaccines market is expected to witness tremendous expansion rate, due to the growing awareness about the benefits of vaccines as compared to other modes of medicine/drug administrations. As vaccines show a considerably less risk of severe side-effects as compared to other anticipated products there is an increasing popularity of the human vaccines market. On the other hand, the growing number of awareness/knowledge programs by different governments and non-profit organizations as well as private associations also anticipates supporting the development and expansion of this market in the coming future.

Human Vaccines MarketRequest Free Sample

The global market for human vaccines is projected to increase and develop at a rapid rate in the future. However, the existence of strict regulatory rules is expected to create obstacles to the growth of this market. Besides, the rapid increase in the cost of these vaccines, along with the handling, transportation, and storage, is also likely to act as a major restraint for the global market in the coming years.

Human Vaccines Market Report Scope

Report Attributes Report Details
Report Name Human Vaccines Market
Market Size in 2023 USD 43.51 Billion
Market Forecast in 2032 USD 61.93 Billion
Growth Rate CAGR of 4.0%
Number of Pages 207
Key Companies Covered GeneOne Life Science Inc., Inovio Pharmaceuticals, Inc., Immunomic Therapeutics, Inc., MedImmune, Pharos Biologicals, Astellas Pharma, Inc., Hoffmann-La Roche AG, Sanofi S.A., F. Boehringer Ingelheim GmbH., and CureVac, among others.
Segments Covered By Application, By Type, and By Region
Regions Covered North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA)
Base Year 2023
Historical Year 2018 to 2022
Forecast Year 2024 - 2032
Customization Scope Avail customized purchase options to meet your exact research needs. Request For Customization

Global Human Vaccines Market: Segmentation

The global human vaccines market has been classified based on products, vaccine type, distribution channel, age group, and geography.

In terms of vaccine type, the market is categorized into attenuated, recombinant, conjugate, combination, inactivated, and others.

Based on the product, the human vaccines market is divided into influenza, pneumococcal, HPV, hepatitis, rotavirus, meningococcal, mumps, measles, typhoid, and others.

Based on age group, the market is classified into adolescent, pediatrics, geriatrics, and adult.

Based on distribution channel, the human vaccines market is categorized into drugstores, hospital, pharmacies, and others.

Global Human Vaccines Market: Regional Analysis

Geographically, the human vaccines market is classified into Europe, North America, the Middle East and Africa, and Asia-Pacific. North America is anticipated to hold the leading position, due to the accessibility of improved healthcare facilities in the region. North America is followed by Europe.

The Middle East & Africa offer huge opportunities and potential for the global human vaccines market. Other factors that are fuelling the market growth in other regions are the policies of international bodies, for instance, World health organization (WHO), growing funds from philanthropy associations such as Melinda Gates and Bill foundation, manufacturing of new vaccines, increasing knowledge of vaccination, development of manufacturing low price vaccines particularly in developing countries. The entrance of China in the human vaccines market affects positively the Asia Pacific region.

Competitive Players

Some of the most important market players in the human vaccines market are

  • GeneOne Life Science Inc.
  • Inovio Pharmaceuticals, Inc.
  • Immunomic Therapeutics, Inc.
  • MedImmune
  • Pharos Biologicals
  • Astellas Pharma, Inc.
  • Hoffmann-La Roche AG
  • Sanofi S.A.
  • F. Boehringer Ingelheim GmbH.
  • and CureVac, among others.

Global Human Vaccines Market: Regional Segment Analysis

  • North America
    • The U.S.
  • Europe
    • The UK
    • France
    • Germany
  • The Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

Table Of Content

Methodology

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed